News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,288 Results
Type
Article (1640)
Company Profile (9)
Press Release (35639)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (15536)
Career Advice (125)
Deals (2310)
Drug Development (3725)
Employer Resources (1)
FDA (573)
Job Trends (787)
News (21239)
Policy (1142)
Tag
Academia (47)
Accelerated approval (2)
Allergies (8)
Alliances (1227)
ALS (7)
Alzheimer's disease (60)
Antibody-drug conjugate (ADC) (17)
Approvals (633)
Artificial intelligence (7)
Autoimmune disease (6)
Automation (2)
Bankruptcy (6)
Best Places to Work (740)
Biosimilars (5)
Biotechnology (6)
Bladder cancer (8)
Breast cancer (37)
Cancer (266)
Cardiovascular disease (30)
Career advice (123)
Career pathing (1)
CAR-T (9)
Cell therapy (22)
Cervical cancer (2)
Clinical research (3436)
Collaboration (46)
Compensation (15)
COVID-19 (70)
CRISPR (5)
C-suite (9)
Cystic fibrosis (17)
Data (393)
Depression (5)
Diabetes (34)
Diagnostics (293)
Digital health (3)
Drug discovery (7)
Drug pricing (4)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (14403)
Employer resources (1)
Events (3793)
Executive appointments (6)
FDA (868)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (35)
Gene editing (11)
Gene therapy (18)
GLP-1 (45)
Government (92)
Guidances (164)
Healthcare (903)
HIV (2)
IgA nephropathy (13)
Immunology and inflammation (7)
Indications (6)
Infectious disease (87)
Inflammatory bowel disease (7)
Influenza (2)
Intellectual property (8)
Interviews (12)
IPO (1667)
Job creations (92)
Job search strategy (113)
Labor market (4)
Layoffs (15)
Legal (195)
Liver cancer (7)
Longevity (1)
Lung cancer (33)
Lymphoma (38)
Management (1)
Manufacturing (16)
MASH (7)
Medical device (809)
Medtech (813)
Mergers & acquisitions (684)
Metabolic disorders (61)
Multiple sclerosis (7)
Neurodegenerative disease (14)
Neuropsychiatric disorders (4)
Neuroscience (115)
NextGen: Class of 2026 (192)
Non-profit (83)
Now hiring (1)
Obesity (19)
Opinion (4)
Ovarian cancer (5)
Pain (11)
Pancreatic cancer (4)
Parkinson's disease (6)
Patents (11)
Patient recruitment (15)
Peanut (4)
People (1052)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase I (833)
Phase II (1324)
Phase III (1474)
Pipeline (686)
Policy (2)
Postmarket research (180)
Preclinical (269)
Press Release (1)
Prostate cancer (21)
Radiopharmaceuticals (10)
Rare diseases (45)
Real estate (154)
Regulatory (1057)
Reports (4)
Research institute (50)
Resumes & cover letters (10)
Rett syndrome (1)
RSV (12)
Schizophrenia (7)
Series A (9)
Series B (6)
Sickle cell disease (11)
Spinal muscular atrophy (11)
Sponsored (1)
Startups (92)
Supply chain (1)
Tariffs (2)
The Weekly (1)
Vaccines (18)
Venture capital (5)
Weight loss (13)
Women's health (3)
Date
Today (5)
Last 7 days (16)
Last 30 days (60)
Last 365 days (2020)
2026 (52)
2025 (2008)
2024 (2236)
2023 (2389)
2022 (3550)
2021 (4092)
2020 (3474)
2019 (1831)
2018 (1318)
2017 (1139)
2016 (718)
2015 (1180)
2014 (784)
2013 (418)
2012 (514)
2011 (683)
2010 (642)
Location
Africa (67)
Alabama (12)
Arizona (13)
Asia (2152)
Australia (314)
California (730)
Canada (175)
China (56)
Colorado (34)
Connecticut (24)
Delaware (44)
Europe (4265)
Florida (102)
Georgia (23)
Idaho (3)
Illinois (51)
India (2)
Indiana (36)
Japan (36)
Kansas (4)
Kentucky (4)
Louisiana (7)
Maine (9)
Maryland (93)
Massachusetts (466)
Michigan (20)
Minnesota (47)
Missouri (8)
Montana (2)
Nevada (3)
New Hampshire (5)
New Jersey (254)
New Mexico (1)
New York (189)
North Carolina (65)
Northern California (385)
Ohio (15)
Oregon (1)
Pennsylvania (168)
Rhode Island (1)
South America (73)
Southern California (296)
Tennessee (6)
Texas (77)
United States (2531)
Utah (18)
Virginia (5)
Washington D.C. (5)
Washington State (50)
Wisconsin (8)
37,288 Results for "105".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
January 5, 2026
·
3 min read
Press Releases
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
October 23, 2025
·
6 min read
Press Releases
March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB-105 CD5 CAR-T Cell Therapy at ASH 2025 Annual Meeting
December 9, 2025
·
4 min read
Press Releases
March Biosciences Announces Oral Presentation of MB-105 Interim Phase 2 Clinical Data at American Society of Hematology Annual Meeting
November 4, 2025
·
3 min read
Press Releases
March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma
November 12, 2025
·
4 min read
Press Releases
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
October 21, 2025
·
4 min read
Press Releases
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads
October 16, 2025
·
4 min read
Press Releases
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
September 12, 2025
·
5 min read
Press Releases
Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year
September 18, 2025
·
6 min read
Collaboration
Crescent, Kelun-Biotech Swap Therapies in ADC-Bispecific Deal Worth Up To $1.25B
The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies plan to push into Phase I/II development for solid tumors early next year.
December 4, 2025
·
2 min read
·
Tristan Manalac
1 of 3,729
Next
